Vaccinated people were completely protected against severe and even moderate cases of illness by the two-shot regimen in a 30,000-person trial conducted when variants had begun to complicate the pandemic in the United States and Mexico.
Novavax’s coronavirus vaccine is 90 percent effective, study finds
